Literature DB >> 23104257

Conversion rates of an interferon-γ release assay and the tuberculin skin test in the serial monitoring of healthcare workers.

S Y Kim1, M S Park, Y S Kim, S K Kim, J Chang, Y A Kang.   

Abstract

PURPOSE: Regular monitoring of latent tuberculosis (TB) infection in healthcare workers (HCWs) is recommended, but the view about the effective method and performance of serial monitoring is controversial. The aim of this study was to determine differences in conversion rates according to TB exposure risk using the tuberculin skin test (TST) and the QuantiFERON-TB Gold In-Tube (QFT-GIT), and to evaluate the reproducibility and within-subject variability of the QFT-GIT in South Korea.
METHODS: Fifty-three HCWs were grouped according to their risk for TB exposure: group 1, high risk (n = 21); group 2, low risk (n = 32). Baseline and follow-up TSTs and QFT-GITs were performed from June 2009 to July 2011. Enzyme-linked immunosorbent assays (ELISAs) were repeated for the second QFT-GIT and a third QFT-GIT was performed after 8 weeks when discordant results of the second TST and QFT-GIT or a conversion or reversion were observed.
RESULTS: No difference in the QFT-GIT conversion rate was evident between the two groups (15.4 vs. 6.5 %, p = 0.57), and no TST conversion was observed. The rate of QFT-GIT positivity was higher in the high-risk group (first QFT-GIT: 38.1 vs. 3.1 %, p = 0.002; second QFT-GIT: 33.3 vs. 9.4 %, p = 0.039). The re-test reproducibility of QFT-GIT results was high (100 %), and the within-subject results of repetitive QFT-GITs were variable.
CONCLUSIONS: Stricter prevention strategies remain necessary in HCWs at high risk of TB exposure, and serial interferon-γ release assays (IGRAs) should be interpreted with caution in HCWs.

Entities:  

Mesh:

Year:  2012        PMID: 23104257     DOI: 10.1007/s15010-012-0356-0

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  27 in total

1.  Incidence of tuberculosis among health care workers at a private university hospital in South Korea.

Authors:  K-W Jo; J H Woo; Y Hong; C-M Choi; Y-M Oh; S D Lee; W S Kim; D S Kim; W D Kim; T S Shim
Journal:  Int J Tuberc Lung Dis       Date:  2008-04       Impact factor: 2.373

2.  Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers.

Authors:  Felix C Ringshausen; Albert Nienhaus; José Torres Costa; Heiko Knoop; Stephan Schlösser; Gerhard Schultze-Werninghaus; Gernot Rohde
Journal:  Clin Vaccine Immunol       Date:  2011-05-18

3.  Sensitivity of neonates to tuberculin after BCG vaccination.

Authors:  J W Hadfield; J Allan; W J Windebank
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-12

Review 4.  The tuberculin skin test.

Authors:  R E Huebner; M F Schein; J B Bass
Journal:  Clin Infect Dis       Date:  1993-12       Impact factor: 9.079

5.  Tuberculin response two years after BCG vaccination at birth.

Authors:  H Grindulis; M I Baynham; P H Scott; R A Thompson; B A Wharton
Journal:  Arch Dis Child       Date:  1984-07       Impact factor: 3.791

6.  Interferon-γ release assay for tuberculosis screening of healthcare workers at a Korean tertiary hospital.

Authors:  Hye Yun Park; Kyeongman Jeon; Gee Young Suh; O Jung Kwon; Doo Ryeon Chung; Sung Won Yoonchang; Eun-Suk Kang; Won-Jung Koh
Journal:  Scand J Infect Dis       Date:  2010-10-11

Review 7.  Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review.

Authors:  Madhukar Pai; Lee W Riley; John M Colford
Journal:  Lancet Infect Dis       Date:  2004-12       Impact factor: 25.071

8.  Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

Authors:  Dick Menzies; Madhukar Pai; George Comstock
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

9.  A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements.

Authors:  L Wang; M O Turner; R K Elwood; M Schulzer; J M FitzGerald
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

10.  Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection.

Authors:  Philip C Hill; Roger H Brookes; Annette Fox; Dolly Jackson-Sillah; David J Jeffries; Moses D Lugos; Simon A Donkor; Ifedayo M Adetifa; Bouke C de Jong; Alex M Aiken; Richard A Adegbola; Keith P McAdam
Journal:  PLoS Med       Date:  2007-06       Impact factor: 11.069

View more
  6 in total

1.  IGRA-positive patients and interferon-gamma/interleukin-2 signatures: can the Fluorospot assay provide further information?

Authors:  P Bittel; D Mayor; P Iseli; T Bodmer; F Suter-Riniker
Journal:  Infection       Date:  2014-01-30       Impact factor: 3.553

2.  Comparison of the interferon-gamma release assay with the traditional methods for detecting Mycobacterium tuberculosis infection in children.

Authors:  Jianwei Zhou; Cui Kong; Yanxi Shi; Zhaocai Zhang; Zhaohong Yuan
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

Review 3.  Diagnosis and Treatment of Latent Tuberculosis Infection in Healthcare Workers.

Authors:  Jeong Ha Mok
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-07-01

4.  Occupational Risk of Latent Tuberculosis Infection in Health Workers of 14 Military Hospitals.

Authors:  Chang Gyo Yoon; Soo Yon Oh; Jin Beom Lee; Mi Hyun Kim; Younsuk Seo; Juyoun Yang; Kyu Jung Bae; Seoyean Hong; Eun Suk Yang; Hee Jin Kim
Journal:  J Korean Med Sci       Date:  2017-08       Impact factor: 2.153

5.  Serial testing of healthcare workers for latent tuberculosis infection and long-term follow up for development of active tuberculosis.

Authors:  Youngmok Park; Song Yee Kim; Jeong Wha Kim; Moo Suk Park; Young Sam Kim; Joon Chang; Young Ae Kang
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

6.  The Prevalence and Risk Factors of Latent Tuberculosis Infection among Health Care Workers Working in a Tertiary Hospital in South Korea.

Authors:  Jae Seuk Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2018-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.